Search

Statistically significant difference in arrested disease in leriglitazone treated patients when compared to the natural history of the disease

Corify Care has secured €6 million in funding to expand its non-invasive cardiac mapping technology, ACORYS, aimed at improving the diagnosis and treatment of arrhythmias.

With an investment of nearly 30 million euros, Kadans will include quality workspaces, with Breeam certification for sustainable building, together with common areas and elements that foster the

The Eugin Group, from its Basic Research Centre at the Barcelona Science Park, is leading a consortium of 15 public and private European institutions in the development of the IMPLANTEU project. This

VIVEbiotech, a company specializing in lentiviral vectors for gene and cell therapies, has received an investment from Ampersand Capital Partners to expand its manufacturing and development capacity

“Decision to grant” communication in Russia